SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001246360-14-003918
Filing Date
2014-09-23
Accepted
2014-09-23 17:14:08
Documents
1
Period of Report
2014-09-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form.html 3  
1 PRIMARY DOCUMENT form.xml 3 2126
  Complete submission text file 0001246360-14-003918.txt   3525
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 33 HAYDEN AVE LEXINGTON MA 02421
Business Address
Bazemore Robert B (Reporting) CIK: 0001620152 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23155 | Film No.: 141116629